CLINICAL_TRIALS
trial_result
· 2020-09-23
Clinical Trial Update: Tolvaptan in Hyponatremic Cancer Patients [Phase 4]
Summary
Phase 4 clinical trial update on tolvaptan in hyponatremic patients with advanced cancers; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Advanced Cancers | Phase 4 | Status: COMPLETED | Results posted: 2020-09-23